Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial.

ABSTRACT:

Introduction

Low-nitrosamine smokeless tobacco (SLT) may have efficacy for smoking reduction and cessation, but its public health impact depends on how smokers use it.

Methods

This pilot study explored brief, instructional low-nitrosamine SLT use among smokers unmotivated to quit. Participants (N = 57) were randomized to either a free 2-week supply of Camel Snus group or a no-supply group. Of those randomized to use Camel Snus, half were told to use it to cope with smoking restrictions (Snus to Cope), and the remaining half were advised to use it to reduce smoking (Snus to Reduce). Participants were assessed before, during, and immediately after the intervention.

Results

Many Snus to Cope and Snus to Reduce participants reported daily use of Camel Snus, although the a

SUBMITTER: Burris JL 

PROVIDER: S-EPMC3954419 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature